Barouch, Dan H.
- Fred Hutchinson Cancer Center (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #11
- Top 1% Funded
- Rising Star
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2002 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$61.2M
Full award amounts, FY2023
Award Records
4
Records listing this PI
Award-Linked Rank
#11
By linked amount among FY2023 PIs
Earliest Year Loaded
2002
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Barouch, Dan H. as a PI. Multi-PI records show the full award amount for context.
- 5UM1AI068614-18UM1Contact PIHIV Vaccines Clinical Trials Network Leadership and Operations Center$38.9Maward amount
- 3UM1AI068614-18S3UM1Contact PICoVPN 3008 - Multi-Center, Randomized, Efficacy Study of COVID-19 mRNA Vaccine in Regions with SARS-CoV-2 Variants of Concern$19.4Maward amount
- 3UM1AI068614-18S1UM1Contact PICoVPN 3005 - Efficacy, Immunogenicity, and Safety of SARS-CoV-2 Recombinant Protein Vaccine with Adjuvant in Adults 18 Years of Age and Older$2.7Maward amount
- $305.3Kaward amount
Award organization
Organizations that administered FY2023 awards listing Barouch, Dan H. as a PI.
FY2023 award administered by Fred Hutchinson Cancer Center (WA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2002First NIH AwardFred Hutchinson Cancer Center
- 2004$500K Cumulative Funding
- 2004$1M Cumulative Funding
- 2004Entered Top 50% NationallyRanked #5317
- 2005$2M Cumulative Funding
- 2005$5M Cumulative Funding
- 2005Entered Top 25% NationallyRanked #404
- 2005Entered Top 10% NationallyRanked #404
- 2005Entered Top 5% NationallyRanked #404
- 2021$10M Cumulative Funding
- 2021$25M Cumulative Funding
- 2021$50M Cumulative Funding
- 2021$100M Cumulative Funding
- 2021Entered Top 1% NationallyRanked #7